Merkel cell carcinoma

Cancer Treatment and Research

Volumn 146, Issue , 2009, Pages 329-341

  Kanitakis, Jean ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; PROTEIN P53; RAPAMYCIN; STEROID; SUNSCREEN; TACROLIMUS; VINCRISTINE;

ANAPLASTIC CARCINOMA; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; GENE MUTATION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MELANOMA; MERKEL CELL TUMOR; METASTASIS; ONCOGENE H RAS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; PUVA; SENTINEL LYMPH NODE BIOPSY; SUN EXPOSURE; ULTRAVIOLET RADIATION; ADULT; AGED; CARCINOMA, MERKEL CELL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ONCOLOGY; PROCEDURES; RISK FACTOR; SKIN NEOPLASMS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; ORGAN TRANSPLANTATION; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 77953674882     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78574-5_27     Document Type: Article

References (65)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105:107-10.
2. Hodgson N. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005; 89:1-4.
3. Medina-Franco H, Urist M, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 24 cases. Ann Surg Oncol 2001; 8:204-8.
4. Agelli M, Clegg LX. Epidemiology of Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49:832-41.
5. Stempfle H, Mudra H, Angermann C, et al. Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. J Heart Lung Transplant 1993; 12:501-3.
6. Formica M, Basolo B, Funaro L, et al. Merkel cell carcinoma in renal transplant recipient. Nephron 1994; 68:399.
7. Douds A, Mellotte G, Morgan H. Fatal Merkel-cell tumour (cutaneous neuroendocrine carcinoma) complicating renal transplantation. Nephrol Dial Transplant 1995; 10:2346-8.
8. Vazquez-Mazariego Y, Vallcorba I, Ferro M, et al. Cytogenetic study of neuroendocrine carcinoma of Merkel cells. Cancer Genet Cytogenet 1996; 92:79-81.
9. Gooptu C, Woolons A, Ross J, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137:637-41.
10. Jonas S, Rayes N, Neumann U, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80:1141-50.
11. Williams R, Morgan M, Mathieson I, et al. Merkel cell carcinoma in a renal transplant patient: increased incidence? Transplantation 1998; 27:1396-97.
12. Plunkett T, Harris A, Ogg C, et al. The treatment of Merkel cell carcinoma and its association with immunosuppression. Br J Dermatol 1998; 139:345-6.
13. Urbatsch A, Sams M, Urist M, et al. Merkel cell carcinoma occurring in renal transplant recipients. J Am Acad Dermatol 1999; 41:289-91.
14. Traest K, De Vos R, van den Oord J. Pagetoid Merkel cell carcinoma: speculations on its origin and the mechanism of epidermal spread. J Cutan Pathol 1999; 26:362-5.
15. Silvestris N, D'Elia F, Tarantino G, et al. Merkel cell carcinoma in a renal transplant patient. J Exp Clin Cancer Res 2000; 19:399-400.
16. Picciotto F, Basolo B, Massara C, Aloi F, Segoloni G, Quarello F. Tumori cutanei rari in pazienti con trapianto d'organo: nostra esperienzia personale e revisione della letteratura. Giorn Ital Dermatol Venereol 2000; 135:597-605.
17. Walsh N. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof. Hum Pathol 2001; 32:680-9.
18. Baron J, Sanchez C, Garcia P. Merkel cell carcinoma in a kidney transplant patient. Rev Clin Esp 2001; 201:223.
19. Friedlaender M, Rubinger D, Rosenbaum E, et al. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 2002; 73:1849-50.
20. Maksimyuk B, Wygoda A, Zakliczynski M, et al. Primary undifferentiated small cell carcinoma (Merkel cell carcinoma) in a patient after heart transplantation - a case report. Pol J Pathol 2002; 53:177-80.
21. Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002; 34:1780-1.
22. Bartsch C, Mechtersheimer G, Helmchen B, et al. Merkel-Zell-Karzinom nach Nierentransplantation. Pathologe 2002; 23:308-12.
23. Clark B, Jukic D, Lourduraj L. Case 398-Multiple cutaneous malignancies and related fatal outcome. Available at: http://path.upmc.edu/cases/case398. html. Accessed April 2007.
24. Morris K, Williams B, Kennedy G. Heavy bone marrow involvement with metastatic Merkel cell tumour in an immunosuppressed renal transplant recipient. Br J Haematol 2005; 128:133.
25. Esen B, Pinarbasi B, Buyukbabani N, et al. Merkel-cell carcinoma arising after liver transplantation: a case report. Transplant Proc 2005; 37:4413-5.
26. Ferreira P, Pinho C, Cardoso A, et al. Unusual Merkel cell carcinoma in a renal transplant recipient: case report and review of the literature. Eur J Plast Surg 2006; 28:426-31.
27. Kanitakis J, Euvrard S, Chouvet B, Butnaru AC, Claudy A. Merkel cell carcinoma in renal transplant recipients. Report of two new cases with unusual histological features and literature review. J Cutan Pathol 2006; 33:686-94.
28. Muirhead R, Ritchie D. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clin Oncol 2007; 19:96.
29. Bensaleh H, Perney P, Dereure O, et al. Merkel cell carcinoma in a liver transplant patient. Am J Clin Dermatol 2007; 8:239-41.
30. Bajetta E, Platania M, Catena L, et al. Merkel cell carcinoma after liver transplantation: a case report. Tumori 2007; 93:323-6.
31. Dantal J, Hourmant M, Cantarovitch D, Mansat E, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 1998; 351:623-8.
32. Bordea C, Wojnarowska F, Millard P, et al. Skin cancer in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77:574-9.
33. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68:1717-21.
34. Miller R, Rabkin C. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153-8.
35. Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007; 25:1043-7.
36. Popp S, Waltering S, Herbst C, et al. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development ofMerkel and skin squamous cell carcinomas. Int J Cancer 2002; 99:352-60.
37. Matichard E, Descamps V, Grossin M, et al. Merkel cell carcinoma in a black human immunodeficiency virus-infected patient. Br J Dermatol 2002; 146:671-3.
38. Vlad R, Woodlock T. Merkel cell carcinoma after chronic lymphatic leukaemia: case report and literature review. Am J Clin Oncol 2003; 26:531-4.
39. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-91.
40. Kanitakis J, Joly MO, Chouvet B, et al. Merkel cell carcinomas in immunocompetent and organ-transplant recipients do not harbor HPV. Eur J Dermatol 2006; 16:445-6.
41. Shaw M, Warren S, Groben P, Gulley M. No evidence of Epstein-Barr virus association with Merkel cell carcinoma. J Cutan Pathol 2006; 33:624-8.
42. Feng H, Shuda M, Chang Y, Moore P. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096-100.
43. Ho SY, Tsai YC, Lee YY, et al. Merkel cell carcinoma in patients with long-term ingestion of arcenic. J Occup Health 2005; 47:188-92.
44. Brenn T, McKee P. Neuroendocrine skin carcinoma. In: McKee P, Calonje E, Granter S (eds) Pathology of the Skin with Clinical Correlations, 3rd edn. Philadelphia: Elsevier Mosby, 2005:1230-8.
45. Rocamora A, Badia N, Vives R, et al. Epidermotropic primary neuroendocrine (Merkel cell) carcinoma of the skin with Pautrier-like microabscesses. Report of three cases and review of the literature. J Am Acad Dermatol 1987; 16:1163.
46. Brown H, Sawyer D, Woo T. Intraepidermal Merkel cell carcinoma with no dermal involvement. Am J Dermatopathol 2000; 22:65-9.
47. Llombart B, Monteagudo C, Lopez-Guerrero J, et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 2005; 46:622-34.
48. Skelton H, Smith K, Hitchkock C, et al.Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997; 37:734-9.
49. Goldberg S, Neifeld J, Frable W. Prognostic value of tumor thickness in patients with Merkel cell carcinoma. J Surg Oncol 2007; 95:618-22 (doi 10.1002/jso.20737).
50. Kanitakis J. Solid cutaneous tumours. In: Kanitakis J, Vassileva S, Woodley D (eds) Diagnostic Immunohistochemistry of the Skin. An Illustrated Text. London: Chapman & Hall, 1998:279-99.
51. Vesely M, Murray D, Neligan P, et al. Complete spontaneous regression in Merkel cell carcinoma. J Plast Reconstr Aesth Surg 2008; 61:165-71.
52. Gupta S, Wang L, Penas P, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006; 142:685-90.
53. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1-17.
54. Veness M, Harris D. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol 2007; 51:12-20.
55. Lewis K, Weinstock M, Weaver A, Otley C. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006; 142:693-700.
56. Boyer J, Zitelli J, Broadland D, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002; 47:885-92.
57. Senchenkov A, Barnes S, Moran S. Predictors of survival and recurrence in the surgical treatment of Merkel cell carcinoma of the extremities. J Surg Oncol 2007; 95:229-34.
58. Clark B, Veness M, Gilbert R, et al. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007; 29:249-57.
59. Jabbour J, Cumming R, Scolyer RA, et al. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease: results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol 2007; 14: 1943-52.
60. Brady M. Current management of patients with Merkel cell carcinoma. Dermatol Surg 2004; 30:321-5.
61. Tai P, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000; 18:2493-99.
62. Swick B, Ravdel L, Fitzpatrick J, et al. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the c-KIT protooncogene - implications for treatment with imatinib mesylate. J Cutan Pathol 2007; 34:324-9.
63. Campistol J, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17:581-9.
64. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8:128-35.
65. Euvrard S, Ulrich C, Lefrançois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004; 30(4 pt 2): 628-33.